Coherus Oncology, Inc. (FRA:8C5)

Coherus Oncology Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 29, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	220	154	336	728	1,078	1,024
Market Cap Growth	34.42%	-54.23%	-53.89%	-32.48%	5.27%	-9.02%
Enterprise Value	104	348	650	909	1,034	953
Last Close Price	1.90	1.41	2.98	6.75	15.00	13.76
PE Ratio	1.66	5.58	-	-	-	9.47
PS Ratio	0.93	0.60	1.44	3.68	3.75	2.63
PB Ratio	2.94	-1.20	-1.92	-5.66	12.54	4.46
P/TBV Ratio	6.73	-	-	-	13.02	4.51
P/FCF Ratio	-	-	-	-	-	8.52
P/OCF Ratio	-	-	-	-	-	8.12
EV/Sales Ratio	0.45	1.35	2.79	4.60	3.60	2.45
EV/EBITDA Ratio	-	-	-	-	-	7.32
EV/EBIT Ratio	-	-	-	-	-	7.46
EV/FCF Ratio	-	-	-	-	-	7.93
Debt / Equity Ratio	0.62	-2.26	-2.49	-3.50	4.29	1.48
Debt / EBITDA Ratio	-	-	-	-	-	2.57
Debt / FCF Ratio	-	-	-	-	-	2.84
Asset Turnover	0.54	0.50	0.46	0.36	0.43	0.76
Inventory Turnover	4.88	1.77	3.14	1.83	1.41	1.39
Quick Ratio	1.19	0.88	1.14	2.17	3.27	4.79
Current Ratio	1.24	1.21	1.43	2.75	3.64	5.27
Return on Equity (ROE)	-	-	-	-	-151.62%	68.49%
Return on Assets (ROA)	-10.26%	-10.94%	-21.75%	-27.68%	-21.68%	15.63%
Return on Invested Capital (ROIC)	-	-89.73%	-120.38%	-204.79%	-205.76%	110.66%
Return on Capital Employed (ROCE)	-58.10%	-57.00%	-64.90%	-75.10%	-51.30%	22.50%
Earnings Yield	60.10%	17.93%	-64.15%	-37.52%	-23.43%	10.56%
FCF Yield	-	-12.86%	-47.16%	-31.01%	-3.16%	11.73%
Buyback Yield / Dilution	-2.22%	-21.95%	-21.30%	-2.89%	9.63%	-14.08%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.